NRXP NRX Pharmaceuticals Inc

Price (delayed)

$3.16

Market cap

$136.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.55

Enterprise value

$111.37M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 18
Highlights
NRX Pharmaceuticals's quick ratio has soared by 193% from the previous quarter
The company's equity has surged by 100% YoY and by 99% QoQ
NRX Pharmaceuticals's debt has plunged by 88% YoY but it has increased by 33% from the previous quarter
NRX Pharmaceuticals's gross margin has decreased by 8% from the previous quarter

Key stats

What are the main financial stats of NRXP

NRXP stock price

How has the NRX Pharmaceuticals stock price performed over time
Intraday
-4.82%
1 week
-5.67%
1 month
-11.24%
1 year
10.88%
YTD
16.61%
QTD
-22.74%

Financial performance

How have NRX Pharmaceuticals's revenue and profit performed over time
Revenue
$3.39M
Gross profit
$1.58M
Operating income
-$19.9M
Net income
-$23.48M
Gross margin
46.6%
Net margin
-691.8%
The operating income has plunged by 53% YoY and by 16% from the previous quarter
The revenue is up by 48% since the previous quarter
The gross profit has increased by 37% since the previous quarter
NRX Pharmaceuticals's net margin has increased by 35% from the previous quarter

Price vs fundamentals

How does NRXP's price correlate with its fundamentals

Growth

What is NRX Pharmaceuticals's growth rate over time

Valuation

What is NRX Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
35.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.82
NRXP's EPS has surged by 75% year-on-year and by 50% since the previous quarter
The company's equity has surged by 100% YoY and by 99% QoQ
The P/S is 65% below the last 4 quarters average of 106.5
The revenue is up by 48% since the previous quarter

Efficiency

How efficient is NRX Pharmaceuticals business performance
NRX Pharmaceuticals's ROA has soared by 81% YoY and by 42% from the previous quarter
NRXP's return on sales is up by 36% since the previous quarter

Dividends

What is NRXP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NRXP.

Financial health

How did NRX Pharmaceuticals financials performed over time
NRX Pharmaceuticals's current ratio has soared by 197% from the previous quarter
NRX Pharmaceuticals's quick ratio has soared by 193% from the previous quarter
The company's equity has surged by 100% YoY and by 99% QoQ
NRX Pharmaceuticals's debt has plunged by 88% YoY but it has increased by 33% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.